{"effective_time":"20171206","id":"2e707d19-ddb9-4285-9dc4-d09fb6552469","openfda":{},"package_label_principal_display_panel":["Principal Display Panel NDC 0007-3650-30 DYAZIDE ® 25 MG HYDROCHLOROTHIAZIDEAND 37.5 MG TRIAMTERENECAPSULES 1000 Capsules R x only Store at controlled room temperature 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F). Protect from light. Dispense in a tight, light-resistant container. Each capsule contains 25 mg hydrochlorothiazide and 37.5 mg triamterene. DYAZIDE capsules meet Drug Release Test 3 as published in the current USP monograph for Triamterene and Hydrochlorothiazide Capsules. Usual Dosage: 1or 2 capsules once daily. See accompanying prescribing information. Important: Use safety closures when dispensing this product unless otherwise directed by physician or requested by purchaser. GlaxoSmithKline RTP, NC 27709 Made in Canada Rev. 4/11 A092648 Dyazide 1000 count label"],"set_id":"dbfa408a-ad8e-4c01-b91d-011c8aab9ce8","spl_product_data_elements":["DYAZIDE hydrochlorothiazide and triamterene HYDROCHLOROTHIAZIDE HYDROCHLOROTHIAZIDE TRIAMTERENE TRIAMTERENE BENZYL ALCOHOL D&C RED NO. 33 FD&C YELLOW NO. 6 GELATIN, UNSPECIFIED GLYCINE LACTOSE, UNSPECIFIED FORM MAGNESIUM STEARATE MICROCRYSTALLINE CELLULOSE POVIDONE, UNSPECIFIED POLYSORBATE 80 TITANIUM DIOXIDE SODIUM STARCH GLYCOLATE TYPE A POTATO CETYLPYRIDINIUM CHLORIDE opaque red opaque white DYAZIDE;SB"],"version":"2"}